
Bernard Lipman
Examiner (ID: 17069)
| Most Active Art Unit | 1505 |
| Art Unit(s) | 1754, 1762, 1505, 1796, 1713, 3307 |
| Total Applications | 3506 |
| Issued Applications | 2903 |
| Pending Applications | 208 |
| Abandoned Applications | 395 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20277525
[patent_doc_number] => 20250302767
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-10-02
[patent_title] => TREATMENT OF CANCER AND AUTOIMMUNE DISORDERS USING NANO POLYMERS OF HISTONE DEACETYLASE INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 18/701581
[patent_app_country] => US
[patent_app_date] => 2022-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23013
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18701581
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/701581 | TREATMENT OF CANCER AND AUTOIMMUNE DISORDERS USING NANO POLYMERS OF HISTONE DEACETYLASE INHIBITORS | Oct 16, 2022 | Pending |
Array
(
[id] => 18383367
[patent_doc_number] => 11654131
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-05-23
[patent_title] => Composition and method of treatment of health issues related to estrogen metabolism with elevated risk factors in females
[patent_app_type] => utility
[patent_app_number] => 17/966901
[patent_app_country] => US
[patent_app_date] => 2022-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 10640
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17966901
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/966901 | Composition and method of treatment of health issues related to estrogen metabolism with elevated risk factors in females | Oct 16, 2022 | Issued |
Array
(
[id] => 18443545
[patent_doc_number] => 11679096
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-06-20
[patent_title] => Composition and method of treatment of elevated ApoE gene expression related health issues
[patent_app_type] => utility
[patent_app_number] => 17/966916
[patent_app_country] => US
[patent_app_date] => 2022-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 10810
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17966916
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/966916 | Composition and method of treatment of elevated ApoE gene expression related health issues | Oct 16, 2022 | Issued |
Array
(
[id] => 18307388
[patent_doc_number] => 20230111288
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-13
[patent_title] => Treatment of Epithelial Cysts by Intracystic Injection of Antineoplastic Particles
[patent_app_type] => utility
[patent_app_number] => 18/046002
[patent_app_country] => US
[patent_app_date] => 2022-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19182
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18046002
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/046002 | Treatment of epithelial cysts by intracystic injection of antineoplastic particles | Oct 11, 2022 | Issued |
Array
(
[id] => 18194839
[patent_doc_number] => 20230048358
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-16
[patent_title] => EDIBLE COMPOSITION FOR ALLEVIATING VISUAL FATIGUE
[patent_app_type] => utility
[patent_app_number] => 17/962753
[patent_app_country] => US
[patent_app_date] => 2022-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4932
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17962753
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/962753 | Edible composition for alleviating visual fatigue | Oct 9, 2022 | Issued |
Array
(
[id] => 19081878
[patent_doc_number] => 20240108679
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-04
[patent_title] => Composition and manufacturing processes of a toxicity free botanical drug for relief from breathing difficulties
[patent_app_type] => utility
[patent_app_number] => 17/958322
[patent_app_country] => US
[patent_app_date] => 2022-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2156
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17958322
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/958322 | Composition and manufacturing processes of a toxicity free botanical drug for relief from breathing difficulties | Sep 30, 2022 | Abandoned |
Array
(
[id] => 19889099
[patent_doc_number] => 20250114411
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-04-10
[patent_title] => SOLID DOSAGE FORMS CONTAINING BACTERIA AND MICROBIAL EXTRACELLULAR VESICLES
[patent_app_type] => utility
[patent_app_number] => 18/694804
[patent_app_country] => US
[patent_app_date] => 2022-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 134163
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -54
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18694804
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/694804 | SOLID DOSAGE FORMS CONTAINING BACTERIA AND MICROBIAL EXTRACELLULAR VESICLES | Sep 21, 2022 | Pending |
Array
(
[id] => 18322222
[patent_doc_number] => 20230120350
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-20
[patent_title] => MANUFACTURE OF PEANUT FORMULATIONS FOR ORAL DESENSITIZATION
[patent_app_type] => utility
[patent_app_number] => 17/948611
[patent_app_country] => US
[patent_app_date] => 2022-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12489
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17948611
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/948611 | MANUFACTURE OF PEANUT FORMULATIONS FOR ORAL DESENSITIZATION | Sep 19, 2022 | Abandoned |
Array
(
[id] => 19227765
[patent_doc_number] => 12007399
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-11
[patent_title] => Method of identifying and treating premature infants at risk for BPD
[patent_app_type] => utility
[patent_app_number] => 17/942396
[patent_app_country] => US
[patent_app_date] => 2022-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5625
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 146
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17942396
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/942396 | Method of identifying and treating premature infants at risk for BPD | Sep 11, 2022 | Issued |
Array
(
[id] => 19612996
[patent_doc_number] => 20240398676
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-05
[patent_title] => COSMETIC METHOD FOR TREATING HAIR WITH OZONE
[patent_app_type] => utility
[patent_app_number] => 18/689987
[patent_app_country] => US
[patent_app_date] => 2022-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7573
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 125
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18689987
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/689987 | COSMETIC METHOD FOR TREATING HAIR WITH OZONE | Aug 31, 2022 | Pending |
Array
(
[id] => 19195254
[patent_doc_number] => 11992472
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-05-28
[patent_title] => Compositions and methods for enhancing the efficacy of contraceptive microbicides
[patent_app_type] => utility
[patent_app_number] => 17/823020
[patent_app_country] => US
[patent_app_date] => 2022-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4975
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17823020
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/823020 | Compositions and methods for enhancing the efficacy of contraceptive microbicides | Aug 28, 2022 | Issued |
Array
(
[id] => 19526512
[patent_doc_number] => 20240350414
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-24
[patent_title] => DIRECT TABLETING AUXILIARY COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 18/684728
[patent_app_country] => US
[patent_app_date] => 2022-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2803
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18684728
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/684728 | DIRECT TABLETING AUXILIARY COMPOSITION | Aug 18, 2022 | Pending |
Array
(
[id] => 18075763
[patent_doc_number] => 20220401375
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-22
[patent_title] => PROTECTING TISSUE AND MITIGATING INJURY FROM RADIATION-INDUCED IONIZING EVENTS
[patent_app_type] => utility
[patent_app_number] => 17/890809
[patent_app_country] => US
[patent_app_date] => 2022-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9007
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 129
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17890809
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/890809 | PROTECTING TISSUE AND MITIGATING INJURY FROM RADIATION-INDUCED IONIZING EVENTS | Aug 17, 2022 | Pending |
Array
(
[id] => 20356161
[patent_doc_number] => 12472140
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-18
[patent_title] => Composition and method for transdermal delivery of cannabidiol (CBD) and tetrahydrocannabinol (THC)
[patent_app_type] => utility
[patent_app_number] => 17/878998
[patent_app_country] => US
[patent_app_date] => 2022-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 3591
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 178
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17878998
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/878998 | Composition and method for transdermal delivery of cannabidiol (CBD) and tetrahydrocannabinol (THC) | Aug 1, 2022 | Issued |
Array
(
[id] => 19845368
[patent_doc_number] => 20250090719
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-03-20
[patent_title] => BIOMATERIALS FOR EMBOLIZATION AND DRUG DELIVERY
[patent_app_type] => utility
[patent_app_number] => 18/291525
[patent_app_country] => US
[patent_app_date] => 2022-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9577
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18291525
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/291525 | BIOMATERIALS FOR EMBOLIZATION AND DRUG DELIVERY | Jul 28, 2022 | Pending |
Array
(
[id] => 19989642
[patent_doc_number] => 20250127864
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-04-24
[patent_title] => SMALL EXTRACELLULAR VESICLES EXPRESSING A DOMINANT NEGATIVE AMPK ALPHA 1 MUTANT FOR USE IN THE TREATMENT OF OBESITY
[patent_app_type] => utility
[patent_app_number] => 18/681466
[patent_app_country] => US
[patent_app_date] => 2022-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24714
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18681466
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/681466 | Small extracellular vesicles expressing a dominant negative AMPK alpha 1 mutant for use in the treatment of obesity | Jul 28, 2022 | Issued |
Array
(
[id] => 19996590
[patent_doc_number] => 20250134812
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-05-01
[patent_title] => SYNTHETIC GLYCOLIPIDS AND GLYCOLIPOSOME COMPOSITIONS : SUITABLE FOR CARGO DELIVERY TO THE CENTRAL NERVOUS SYSTEM
[patent_app_type] => utility
[patent_app_number] => 18/833456
[patent_app_country] => US
[patent_app_date] => 2022-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19755
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -89
[patent_words_short_claim] => 128
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18833456
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/833456 | SYNTHETIC GLYCOLIPIDS AND GLYCOLIPOSOME COMPOSITIONS : SUITABLE FOR CARGO DELIVERY TO THE CENTRAL NERVOUS SYSTEM | Jul 25, 2022 | Pending |
Array
(
[id] => 18018856
[patent_doc_number] => 20220370355
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => Lapatinib particles and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/812479
[patent_app_country] => US
[patent_app_date] => 2022-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7782
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17812479
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/812479 | Lapatinib particles and uses thereof | Jul 13, 2022 | Issued |
Array
(
[id] => 19968439
[patent_doc_number] => 12337022
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-06-24
[patent_title] => Use of a vegetable extract from salvia haenkei as an active agent in the treatment of heart diseases
[patent_app_type] => utility
[patent_app_number] => 18/576171
[patent_app_country] => US
[patent_app_date] => 2022-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 0
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18576171
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/576171 | Use of a vegetable extract from salvia haenkei as an active agent in the treatment of heart diseases | Jun 30, 2022 | Issued |
Array
(
[id] => 19345203
[patent_doc_number] => 20240254166
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-01
[patent_title] => COMPOSITIONS AND METHODS FOR INHIBITING AN INFLAMMATORY RESPONSE AND TREATING INFLAMMATORY DISEASES
[patent_app_type] => utility
[patent_app_number] => 18/564822
[patent_app_country] => US
[patent_app_date] => 2022-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50888
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18564822
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/564822 | Compositions and methods for inhibiting an inflammatory response and treating inflammatory diseases | May 26, 2022 | Issued |